Table 2.

Univariate and multivariate analyses of prognostic parameters for survival in patients with pancreatic ductal adenocarcinoma (PDAC)

	Univariate analysis				Multivariate analysis
Prognostic parameter		95% CI				95% CI
	RR	Lower	Upper	Pvalue	RR	Lower	Upper	Pvalue
Expression of GOLPH3 (low vs. high)	1.915	1.186	3.092	0.008*	2.733	1.578	4.732	0.000*
Gender (male vs. female)	0.977	0.643	1.484	0.913	1.008	0.647	1.571	0.972
Age (<61 vs. ≥61)	1.295	0.865	1.938	0.209	1.319	0.840	2.073	0.229
Tumor location (head vs. body/tail)	0.882	0.521	1.493	0.640	0.619	0.349	1.100	0.102
Pathologic differentiation (well vs. moderate/poor)	1.402	0.610	3.223	0.426	0.760	0.308	1.874	0.760
Size (≤2 cm vs. >2 cm)	1.940	1.095	3.437	0.023*	1.557	0.841	2.883	0.159
T classification (T1 vs. T2 vs. T3 vs. T4)	1.187	0.941	1.496	0.148	1.001	0.658	1.521	0.998
N classification (absent vs. present)	1.075	0.718	1.611	0.725	0.608	0.386	0.957	0.032*
Liver metastasis (absent vs. present)	1.288	0.779	2.130	0.324	1.002	0.319	3.152	0.997
Clinical stage (I vs. II vs. III vs. IV)	1.243	1.014	1.523	0.036*	1.420	0.776	2.598	0.255
Treatment (radical vs. palliative)	2.444	1.609	3.710	0.000*	2.828	1.745	4.584	0.000*

Univariate analysis and multivariate analyses were analyzed by Cox regression.

^*Statistically significant; RR: Relative Risk; 95% CI: 95% confidence interval.